Article
A Randomized Controlled Trial of Ivermectin Monotherapy versus Hydroxychloroquine, Ivermectin, and Azithromycin Combination Therapy in COVID- 19 Patients in Nigeria
2021-10-31
Abstract excerpt
2-way Repeated measures Analysis of Variance (RMANOVA) did not show any difference between the two groups. However, there was a significant time effect (improvement over time) for SpO<sub>2</sub>, Ct N-gene, Ct E-gene and clinical status in both groups, and significant reductions in inflammatory markers by day 7 (P < 0.0001).
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 180e17af-48a2-5a3d-89b6-64e7b416f20a
- DOI
- 10.23937/2474-3658/1510233
